We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Cannabinoid Technologies Holdings Plc | LSE:OCTP | London | Ordinary Share | GB00BMVMRB86 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.005 | -1.43% | 0.345 | 0.33 | 0.36 | 0.35 | 0.345 | 0.35 | 751,855 | 12:11:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 0 | -5.95M | -0.0062 | -0.55 | 3.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/3/2023 14:33 | News could drop anytime now.. Exciting times ahead. | pillow | |
20/3/2023 11:42 | -- Pre-clinical activities for the Company's lead programme, OCT461201 (programme 1), remained on track and on budgeto Phase I clinical trial is due to commence in Q1 2023 with interim results anticipated in Q2 2023 | zxie | |
19/3/2023 08:17 | This shares Similar to PYC . as long as the result is positive. Easy Jump up 20p | zxie | |
18/3/2023 10:25 | oh the suspense! maybe mon or tues for long overdue news, always seems to be good news at the start of a week (to allow for a sustained rally), or bad news on thurs, so a terrible drop cannot gain pace without the weekend halt to a sustained fall... | sweetg | |
15/3/2023 10:52 | News is long overdue.... | sweetg | |
15/3/2023 08:21 | 2p looking for today | zxie | |
15/3/2023 07:38 | This Phase I first-in-human clinical trial, due to commence in Q1 2023, which is being funded entirely from OCTP's existing resources, will be conducted in the UK in healthy volunteers, with a single ascending dose. The trial aims to demonstrate the safety and tolerability of OCT461201, whilst also providing pivotal information on its pharmacokinetic profile, to confirm its value as a potential drug. The clinical trial is anticipated to complete within Q2 2023. | zxie | |
15/3/2023 07:32 | Moving before news | zxie | |
14/3/2023 17:08 | Cannabinoid Mongoloid | saint in exile | |
14/3/2023 14:34 | Nice volume | zxie | |
14/3/2023 09:25 | I've duly given a nod to OCTP on the HELD thread. | oakridge | |
14/3/2023 09:01 | Good start, good volumes another strong day ahead. | pillow | |
14/3/2023 08:48 | 2p afternoon | zxie | |
13/3/2023 17:03 | There you go FXL5 a proper link ;0) | saint in exile | |
13/3/2023 16:51 | News over due | zxie | |
13/3/2023 15:45 | Cheap stock running out :)) | the onedin line | |
13/3/2023 14:58 | Agree think it will move ahead sharply from that base this week. Good strong volumes and vunerablw to takeover after first key hurdle passed. | pillow |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions